Plasmanate Solution
Product Images NDC 13533-613

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasmanate (NDC 13533-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Plasmanate Carton (Carton250)

Packaging label for Plasmanate 5% Solution, Plasma Protein Fraction (Human), 250 mL for intravenous infusion. The label shows product details including heated treatment instructions, electrolyte content, and warnings. Labeler is Grifols USA, LLC, with NDC 13533-613-25.*

FDA Label Image

Plasmanate Vial (Label250)

Plasmanate (Plasma Protein Fraction Human) 5% solution, 250 mL, for intravenous use. The label states heated at 60°C for 10 hours, with a description of contents including 5 g of plasma proteins per 100 mL, buffered with sodium carbonate and stabilized with sodium caprylate and acetyltryptophan. It includes storage instructions, dosage guidance for single-dose vials, and a table of approximate electrolytes per liter. Manufactured by Grifols Therapeutics LLC, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.